Corp Symetryx's Net Worth
Corp Symetryx's net worth is estimated to be at least $385,365.04 as of 12/27/2024. CoreStreet's estimation of Corp Symetryx's net worth is based on their sale of stock and current holding of stock.
Corp Symetryx is Major Shareholder at NeuBase Therapeutics Inc. They have executed at least 4 trades of stock as per SEC Form 4 filings. Their most recent trade was for 129,108 units of NBSE stock on 09/14/2023. Their biggest sale was on 09/14/2023 when they sold 129,108 units of NeuBase Therapeutics Inc stock for $185,915.52. They typically trade 4 times per year.
Total value of insider buys:
- $59,854.48
Total value of insider sells:
- $325,510.56
Most recent insider trade:
- Sept. 14, 2023
Corp Symetryx's Insider Trading History
NeuBase Therapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Sept. 14, 2023 | Major Shareholder | 129,108 | $1.44 | Sell | $185,915.52 |
Sept. 11, 2023 | Major Shareholder | 3,376 | $1.44 | Sell | $4,861.44 |
Sept. 7, 2023 | Major Shareholder | 74,852 | $1.80 | Sell | $134,733.60 |
Sept. 1, 2023 | Major Shareholder | 61,076 | $0.98 | Buy | $59,854.48 |